Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Scottish Biotech ILC Therapeutics Sets Sights on Series A and IPO After Recent Investment Round
Life Sciences Times
-
April 26, 2023
0
Venture Capital
Orbital Therapeutics Secures $270 Million in Series A Financing to Unleash Full Potential of RNA Medicines
Life Sciences Times
-
April 26, 2023
0
Venture Capital
Enanta Pharmaceuticals Announces Sale of a Portion of Global Royalties on MAVYRET® to OMERS Life Sciences for $200 Million
Life Sciences Times
-
April 25, 2023
0
Venture Capital
Enveda Biosciences Announces Oversubscribed Series B1 Bringing Total Round to US$119 Million
Life Sciences Times
-
April 20, 2023
0
Venture Capital
Gather Health, a New Primary Care Model for Older Adults, Opens First Practice in Massachusetts with $15M Series A Funding
Life Sciences Times
-
April 19, 2023
0
Venture Capital
3D Glass Solutions Closes $30 Million Series C Funding Round
Life Sciences Times
-
April 19, 2023
0
Venture Capital
Arcadia Raises $125 Million in New Financing from Vista Credit Partners
Life Sciences Times
-
April 13, 2023
0
Venture Capital
Red Cell Partners Announces $3 Million in Pre-Seed Funding for Psychedelic Company TARA Mind
Life Sciences Times
-
April 13, 2023
0
Venture Capital
Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1
Life Sciences Times
-
April 13, 2023
0
Venture Capital
Mosaic Therapeutics Closes $28m Series A Funding and Appoints Brian Gladsden as CEO
Life Sciences Times
-
April 4, 2023
0
Venture Capital
Cure Ventures Launches with the Close of Inaugural $350 Million Fund
Life Sciences Times
-
April 4, 2023
0
Venture Capital
Elara Caring Announces Plan to Acquire Assisted Daily Living
Life Sciences Times
-
April 3, 2023
0
1
...
47
48
49
...
115
Page 48 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026